The Intensive Hospital Monitoring for Adverse Drug Reactions of Yang-Xin-Shi Tablet

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-12002633

Enrollment

Unknown

Registered

2012-10-15

Start date

2012-11-09

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diseases listed in the package Insert of Yang-Xin-Shi Tablet

Interventions

Observed Group:Yang-Xin-Shi tablet

Eligibility

Sex/Gender

Male

Age

11 Years to 100 Years

Inclusion criteria

Inclusion criteria: all the patients that used Yang-Xin-Shi Tablet and accord with ethics requirements in the research centers

Exclusion criteria

Exclusion criteria: patients used Yang-Xin-shi Tablet not in accordance with the instruction

Design outcomes

Primary

Measure	Time frame
the incidence of severe adverse drug reaction;	—

Secondary

Measure	Time frame
the incidence of adverse drug reaction;	—

Countries

China

Contacts

Public ContactZhong Wang

zhonw@vip.sina.com+86 010 64014411-3308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026